HSV1 vectors to study protein targeting in neurones: are glycosyl-phosphatidylinositol anchors polarized targeting signals in neurones?

Abstract:

:In order to characterize protein targeting signals in polarized postmitotic cortical neurones in vitro, we have developed recombinant and amplicon type vectors derived from herpes simplex virus 1 (HSV1) to transfer genes into these cells. We examined the targeting of both bacterial proteins, which lack specific targeting signals, as well as recombinant proteins containing mammalian targeting sequences, i.e. the sequence encoding for the addition of a glycosyl-phosphatidyl inositol (GPI) membrane anchor. Utilizing both HSV1 recombinant and amplicon vectors we demonstrate that while a GPI anchor is able to direct a foreign protein to the plasma membrane, the recombinant protein is targeted mainly to the dendritic, but also to the axonal plasma membrane; i.e. its distribution is not completely polarized. Thus, GPI anchors do not function as dominant polarized targeting signals in neurones, as they do in polarized epithelial cell lines.

journal_name

Gene Ther

journal_title

Gene therapy

authors

Lowenstein PR,Bain D,Morrison EE,Preston CM,Clissold P,Fournel S,Epstein A,Castro MG

subject

Has Abstract

pub_date

1994-01-01 00:00:00

pages

S32-5

eissn

0969-7128

issn

1476-5462

journal_volume

1 Suppl 1

pub_type

杂志文章
  • Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line.

    abstract::We report the discovery, on routine screening, of a replication-competent retrovirus (RCR) produced from a third generation amphotropic packaging cell line, GP + envAM12. In this line, the gag-pol and env helper genes are located on separate plasmids to minimise the chances of recombination events that may lead to RCR...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:

    authors: Chong H,Vile RG

    更新日期:1996-07-01 00:00:00

  • Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells.

    abstract::Glioblastoma multiforme (GBM) is one of the most formidable brain tumors with a mean survival period of approximately 12 months. To date, a combination of radiotherapy and chemotherapy with an oral alkylating agent, temozolomide (TMZ), has been used as first-line therapy for glioma. However, the efficacy of chemothera...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.88

    authors: Kato T,Natsume A,Toda H,Iwamizu H,Sugita T,Hachisu R,Watanabe R,Yuki K,Motomura K,Bankiewicz K,Wakabayashi T

    更新日期:2010-11-01 00:00:00

  • Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.

    abstract::RNA interference (RNAi) was reported to block hepatitis B virus (HBV) gene expression and replication in vitro and in vivo. However, it remains a technical challenge for RNAi-based therapy to achieve long-term and complete inhibition effects in chronic HBV infection, which presumably requires more extensive and unifor...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302846

    authors: Chen CC,Ko TM,Ma HI,Wu HL,Xiao X,Li J,Chang CM,Wu PY,Chen CH,Han JM,Yu CP,Jeng KS,Hu CP,Tao MH

    更新日期:2007-01-01 00:00:00

  • Clinical retroviral vector production: step filtration using clinically approved filters improves titers.

    abstract::Production of retroviral vectors for clinical use requires removal of cells and cellular debris. We combined a series of filters of decreasing pore size using commercially available blood banking filters approved for clinical use. The collection bag and filters can be connected to create a sterile, closed system using...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301328

    authors: Reeves L,Cornetta K

    更新日期:2000-12-01 00:00:00

  • Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.

    abstract::Viral gene vectors often rely on packaging cell lines, which provide the necessary factors in trans for the formation of virus-like particles. Previously, we reported on a first-generation packaging cell line for gene vectors, which are based on the B-lymphotropic Epstein-Barr virus (EBV), a human gamma-herpesvirus. T...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302714

    authors: Hettich E,Janz A,Zeidler R,Pich D,Hellebrand E,Weissflog B,Moosmann A,Hammerschmidt W

    更新日期:2006-05-01 00:00:00

  • Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components.

    abstract::We introduce a lung inflation-fixation protocol to examine the distribution and gene transfer efficiency of fluorescently tagged lipoplexes using fluorescence confocal microscopy within thick lung tissue sections. Using this technique, we tested the hypothesis that factors related to lipoplex distribution were the pre...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301461

    authors: Uyechi LS,Gagné L,Thurston G,Szoka FC Jr

    更新日期:2001-06-01 00:00:00

  • Incorporation of beta-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression.

    abstract::Polynucleotide immunization has been employed as a means of inducing immune responses through the introduction of antigen-encoding DNA. While immunization against specific tumor antigens may be achieved through this strategy, various candidate tumor antigens may not be approached via DNA-based vaccines as they represe...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300423

    authors: Strong TV,Hampton TA,Louro I,Bilbao G,Conry RM,Curiel DT

    更新日期:1997-06-01 00:00:00

  • Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy.

    abstract::A major concern of using viral gene therapy is the potential for uncontrolled vector propagation and infection that might result in serious deleterious effects. To enhance the safety, several viral vectors, including vectors based on Sindbis virus, were engineered to lose their capability to replicate and spread after...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2008.153

    authors: Tseng JC,Daniels G,Meruelo D

    更新日期:2009-02-01 00:00:00

  • The relevance of coagulation factor X protection of adenoviruses in human sera.

    abstract::Intravenous delivery of adenoviruses is the optimal route for many gene therapy applications. Once in the blood, coagulation factor X (FX) binds to the adenovirus capsid and protects the virion from natural antibody and classical complement-mediated neutralisation in mice. However, to date, no studies have examined th...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2016.32

    authors: Duffy MR,Doszpoly A,Turner G,Nicklin SA,Baker AH

    更新日期:2016-07-01 00:00:00

  • Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.

    abstract::Relaxin-3 is a neuropeptide that is abundantly expressed by discrete brainstem neuron populations that broadly innervate forebrain areas rich in the relaxin-3 G-protein-coupled-receptor, RXFP3. Acute and subchronic central administration of synthetic relaxin-3 or an RXFP3-selective agonist peptide, R3/I5, increase fee...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2012.83

    authors: Ganella DE,Callander GE,Ma S,Bye CR,Gundlach AL,Bathgate RA

    更新日期:2013-07-01 00:00:00

  • Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway.

    abstract::In this study, we describe a simple system in which human keratinocytes can be redirected to an alternative differentiation pathway. We transiently transfected freshly isolated human skin keratinocytes with the single transcription factor OCT4. Within 2 days these cells displayed expression of endogenous embryonic gen...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.148

    authors: Racila D,Winter M,Said M,Tomanek-Chalkley A,Wiechert S,Eckert RL,Bickenbach JR

    更新日期:2011-03-01 00:00:00

  • Genome medicine: gene therapy for the millennium, 30 September-3 October 2001, Rome, Italy.

    abstract::The recent surge of DNA sequence information resulting from the efforts of agencies interested in deciphering the human genetic code has facilitated technological developments that have been critical in the identification of genes associated with numerous disease pathologies. In addition, these efforts have opened the...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301740

    authors: Gruenert DC,Novelli G,Dallapiccola B,Colosimo A

    更新日期:2002-06-01 00:00:00

  • PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.

    abstract::The oncotropic phenotypes of several viruses correlate with tumor-associated deficiencies within interferon (IFN) signaling pathways. This observation formed the conceptual basis for developing oncolytic viruses deleted for viral proteins that inhibit the host IFN-dependent antiviral response, such as herpes simplex v...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.68

    authors: Sobol PT,Hummel JL,Rodrigues RM,Mossman KL

    更新日期:2009-09-01 00:00:00

  • Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.

    abstract::Angiogenesis plays a pivotal role in tumor growth, tissue invasion and metastasis. Endostatin is an angiogenesis inhibitor and has been shown to reduce tumor growth in animal models. However, therapy with recombinant endostatin protein was hampered by its short half-life and very-low yield of bioactive protein. We per...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3303038

    authors: Li HL,Li S,Shao JY,Lin XB,Cao Y,Jiang WQ,Liu RY,Zhao P,Zhu XF,Zeng MS,Guan ZZ,Huang W

    更新日期:2008-02-01 00:00:00

  • Selective cell ablation in transgenic mice expression E. coli nitroreductase.

    abstract::The gene encoding E. coli nitroreductase (NTR) was expressed in the luminal cells of the mammary gland of transgenic mice using the ovine beta-lactoglobulin promoter. Treatment of NTR expressing animals with the prodrug CB1954 (5-aziridin-1-yl-2-4-dinitrobenzamide) resulted in a rapid and selective killing of this pop...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300367

    authors: Clark AJ,Iwobi M,Cui W,Crompton M,Harold G,Hobbs S,Kamalati T,Knox R,Neil C,Yull F,Gusterson B

    更新日期:1997-02-01 00:00:00

  • miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity.

    abstract::The production of high-titer recombinant adeno-associated virus (rAAV) vector is essential for treatment of genetic diseases affecting the retina and choroid, where anatomical constraints may limit injectable volumes. Problematically, cytotoxicity arising from overexpression of the transgene during vector production f...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2017.50

    authors: Reid CA,Boye SL,Hauswirth WW,Lipinski DM

    更新日期:2017-08-01 00:00:00

  • On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids.

    abstract::The mechanism whereby cationic lipids destabilize cell membranes to facilitate the intracellular delivery of macromolecules such as plasmid DNA or antisense oligonucleotides is not well understood. Here, we show that cationic lipids can destabilize lipid bilayers by promoting the formation of nonbilayer lipid structur...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301506

    authors: Hafez IM,Maurer N,Cullis PR

    更新日期:2001-08-01 00:00:00

  • Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells.

    abstract::Cell transplantation holds promise as a potential treatment for cardiac dysfunction. Our group has isolated populations of murine skeletal muscle-derived stem cells (MDSCs) that exhibit stem cell-like properties. Here, we investigated the fate of MDSCs after transplantation into the hearts of dystrophin-deficient mdx ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302521

    authors: Payne TR,Oshima H,Sakai T,Ling Y,Gharaibeh B,Cummins J,Huard J

    更新日期:2005-08-01 00:00:00

  • Gene-based approaches for the repair of articular cartilage.

    abstract::Gene transfer technology has opened novel treatment avenues toward the treatment of damaged musculoskeletal tissues, and may be particularly beneficial to articular cartilage. There is no natural repair mechanism to heal damaged or diseased cartilage. Existing pharmacologic, surgical and cell based treatments may offe...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/sj.gt.3302201

    authors: Trippel SB,Ghivizzani SC,Nixon AJ

    更新日期:2004-02-01 00:00:00

  • Isolation of more potent oncolytic paramyxovirus by bioselection.

    abstract::Newcastle disease virus (NDV) is an oncolytic paramyxovirus with a nonsegmented single-stranded RNA genome. In this report, a recombinant oncolytic NDV was passaged in human tumor xenografts and reisolated and characterized after two rounds of bioselection. Several isolates could be recovered that differed from the pa...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2012.13

    authors: Beier R,Hermiston T,Mumberg D

    更新日期:2013-01-01 00:00:00

  • An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants.

    abstract::Most neoplasms do not induce antitumor immune responses that can control tumor growth. Tumor associated antigens (TAAs) are insufficiently immunogenic. A vaccine that augments the immunogenic properties of TAAs could be of importance in the treatment of cancer patients. In an animal model, we prepared a vaccine by tra...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301765

    authors: de Zoeten EF,Markovic D,Cohen EP

    更新日期:2002-09-01 00:00:00

  • Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.

    abstract::Galactose(alpha1,3)galactose on the surface of cells of non-primate organs is the major xenoantigen responsible for hyperacute rejection in xenotransplantation. The antigen is synthesised by (alpha1, 3)galactosyl transferase. Humans lack this enzyme and their serum contains high levels of pre-existing natural antibody...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300934

    authors: Jäger U,Takeuchi Y,Porter C

    更新日期:1999-06-01 00:00:00

  • Intratumor RNA interference of cell cycle genes slows down tumor progression.

    abstract::Small interfering RNAs (siRNAs) are emerging as promising therapeutic tools. However, the widespread clinical application of such molecules as modulators of gene expression is still dependent on several aspects that limit their bioavailability. One of the most promising strategies to overcome the barriers faced by gen...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2011.27

    authors: Dharmapuri S,Peruzzi D,Marra E,Palombo F,Bett AJ,Bartz SR,Yong M,Ciliberto G,La Monica N,Buser CA,Toniatti C,Aurisicchio L

    更新日期:2011-07-01 00:00:00

  • Delivering multiple gene products in the brain from a single adeno-associated virus vector.

    abstract::For certain gene therapy applications, the simultaneous delivery of multiple genes would allow for novel therapies. In the case of adeno-associated virus (AAV) vectors, the limited packaging capacity greatly restricts current methods of carrying multiple transgene cassettes. To address this issue, a recombinant AAV (r...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.106

    authors: Foti SB,Samulski RJ,McCown TJ

    更新日期:2009-11-01 00:00:00

  • Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system.

    abstract::Gene therapy is a potential new strategy for the treatment of cardiovascular disease. The most efficacious method of gene delivery remains a key hurdle to effective gene therapy. We present the application of a novel, nonviral gene delivery system (TerplexDNA) to augment myocardial transfection. The hearts of New Zeal...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301395

    authors: Affleck DG,Yu L,Bull DA,Bailey SH,Kim SW

    更新日期:2001-03-01 00:00:00

  • Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors.

    abstract::Ideal methods for human gene therapy will eventually include direct gene transfer to defective tissues in a patient in vivo. Toward that goal, we have used high titer, pseudotyped retroviral vectors expressing genes for the Escherichia coli beta-galactosidase (lacZ) or hepatitis B virus surface antigen (HBsAg) to infe...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:

    authors: Miyanohara A,Yee JK,Bouic K,LaPorte P,Friedmann T

    更新日期:1995-03-01 00:00:00

  • Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.

    abstract::Replicating viruses for cancer gene therapy have beneficial antitumor effects, however, in the setting of an enzyme/prodrug system, the interactions between these viruses and the activated agents are complex. A replicating vaccinia virus expressing the cytosine deaminase gene (VVCD), which converts the prodrug 5-FC in...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301237

    authors: McCart JA,Puhlmann M,Lee J,Hu Y,Libutti SK,Alexander HR,Bartlett DL

    更新日期:2000-07-01 00:00:00

  • High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis.

    abstract::Introducing exogenous genes into cells is one of the most important molecular techniques to study gene functions. Comparing to other type of cells, neurons are more difficult to transfect with cDNAs because they are very sensitive to microenvironmental changes. Among various gene transfer techniques, the Ca(2+)-phosph...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302305

    authors: Jiang M,Deng L,Chen G

    更新日期:2004-09-01 00:00:00

  • AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage.

    abstract:UNLABELLED:The aim of this study was to determine the effect of RNA interference inhibition of mineralocorticoid receptor (MR) on cold-induced hypertension (CIH) and renal damage. Recombinant adeno-associated virus (AAV) carrying short hairpin small interference (si)RNA for MR (AAV.MR-shRNA) was constructed and tested ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302768

    authors: Wang X,Skelley L,Cade R,Sun Z

    更新日期:2006-07-01 00:00:00

  • Adenovirus vectors for gene transduction into mobilized blood CD34+ cells.

    abstract::Mobilized blood CD34+ cells from cancer patients were ex vivo infected by a recombinant adenovirus vector carrying an alkaline phosphatase gene, whose expression is evaluable by flow cytometry. A mean of 40% CD34+ cells were infected by the vector, with high levels of expression of the transgene. Among attempts to imp...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300620

    authors: Bregni M,Shammah S,Malaffo F,Di Nicola M,Milanesi M,Magni M,Matteucci P,Ravagnani F,Jordan CT,Siena S,Gianni AM

    更新日期:1998-04-01 00:00:00